Korean J Med.  2009 Sep;77(3):290-297.

Advances in the treatment of hepatocellular carcinoma

Affiliations
  • 1Department of Internal Medicine, Inje University College of Medicine, Ilsanpaik Hospital, Goyang, Korea.

Abstract

There have been recent advances in the treatment of hepatocellular carcinoma (HCC). There has been a clear change in the presentation of HCC, with an increased detection of tumors <2 cm in diameter as result of surveillance programs. In addition, the development of effective local treatment methods has led to the necessity for the selection of base therapeutic modalities on each patient's characteristics. New promising image-guided therapies and new drugs, such as sorafenib, may address the enormous need for expanded treatment options for patients with HCC. Tailored therapies are needed to improve the treatment response and, ultimately, patient survival. Here, we review these advances in the management of HCC.

Keyword

Hepatocellular carcinoma; Therapy

MeSH Terms

Carcinoma, Hepatocellular
Humans
Niacinamide
Phenylurea Compounds
Niacinamide
Phenylurea Compounds
Full Text Links
  • KJM
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2022 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr